Post by healthy11 on Mar 28, 2019 17:27:08 GMT -5
chadd.org/adhd-weekly/which-meds-new-research-points-to-a-difference-in-stimulants-for-adults-children/
A portion of the article says, "The researchers surveyed 133 clinical trials that included a combined 14,000 children and teens and 10,000 adults who participated in those trials. In this meta-analysis, they looked at how well the medications worked at reducing symptoms and the safety of amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate and modafinil, along with a placebo, during a 12-week period.
Comparing the effectiveness between the two groups, stimulant medication and non-stimulant medication, the researchers concluded stimulants were more effective at treating ADHD symptoms in both children and adults. Their next finding was a little surprising.
“Evidence from our network meta-analysis supports methylphenidate (in children and adolescents) and amphetamines (in adults) as the preferred first pharmacological choice for short-term pharmacological treatment of ADHD,” the researchers write. Meaning children and teens responded better when prescribed a methylphenidate (brand names include Ritalin, Focalin, Concerta, and Quilllivant) while adults respond better to amphetamines (brand names include Adderall and Vyvance)."
A portion of the article says, "The researchers surveyed 133 clinical trials that included a combined 14,000 children and teens and 10,000 adults who participated in those trials. In this meta-analysis, they looked at how well the medications worked at reducing symptoms and the safety of amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate and modafinil, along with a placebo, during a 12-week period.
Comparing the effectiveness between the two groups, stimulant medication and non-stimulant medication, the researchers concluded stimulants were more effective at treating ADHD symptoms in both children and adults. Their next finding was a little surprising.
“Evidence from our network meta-analysis supports methylphenidate (in children and adolescents) and amphetamines (in adults) as the preferred first pharmacological choice for short-term pharmacological treatment of ADHD,” the researchers write. Meaning children and teens responded better when prescribed a methylphenidate (brand names include Ritalin, Focalin, Concerta, and Quilllivant) while adults respond better to amphetamines (brand names include Adderall and Vyvance)."